Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is comparing Lorazepam with placebo for people with depression or anxiety. Participants receive Lorazepam or placebo and complete study visits and assessments.
This study is looking at whether Demographic Matching can help people with Depression or Anxiety. Participants take part in Demographic Matching and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing ARTEMIS with Waitlist Control (WLC) for people with Stimulant Use, Human Immunodeficiency Virus, or Depression. Participants receive ARTEMIS or Waitlist Control (WLC) and complete study visits and assessments.
This study is comparing Walk-and-talk therapy with Waitlist control for people with depression or anxiety. Participants receive Walk-and-talk therapy or Waitlist control and complete study visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Depression in Adolescence or Anxiety. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with Mental Health Literacy or Depression, Anxiety. Participants take part in a digital support tool and complete follow-up assessments.
This observational study is following people with Depression anxiety, Adjustment Disorders, Adjustment Disorder With Anxious Mood, or Adjustment Disorder With Depressed Mood to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether Sleep on Schedule can help people with depression or anxiety. Participants take part in Sleep on Schedule and complete follow-up assessments.
This study is comparing Psilocybin and Psilocyn with placebo for people with depression. Participants receive Psilocybin and Psilocyn or placebo and complete study visits and assessments.
This study is comparing Psilocybin (drug) with placebo for people with Treatment Resistant Depression. Participants receive Psilocybin (drug) or placebo and complete study visits and assessments.
This study is looking at whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy for people with Parkinson Disease or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Psilocybin with placebo for people with depression. Participants receive Psilocybin or placebo and complete study visits and assessments.
This study is looking at also assess whether psilocybin may improve quality of life in those individuals for people with Depressive Symptoms, Depression, Alzheimer Disease, or Mild Cognitive Impairment. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at determine the safety and feasibility of performing psilocybin-assisted psychotherapy in patients hospitalized for treatment-resistant depression for people with Treatment Resistant Depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether questionnaires and follow-up can help people with Treatment Resistant Depression or Autism Spectrum Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Chronic Low-back Pain or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Spinal Cord Injury, Depression - depression, or Veteran. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at see if one or two doses of psilocybin is more effective in relieving depressive symptoms in patients with treatment-resistant depression (TRD) for people with depression or Treatment-Resistant Depression. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Psilocybin can help people with Depression, Anxiety, Psilocybin-Assisted Psychotherapy, or Advanced Cancer. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Psilocybin can help people with Psychological Stress, Depression, or Anxiety. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Lung Non-Small Cell Carcinoma or Unipolar Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Refractory Depression or Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with depression or anxiety. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.